FirsthandHealth
medRxiv PreprintsInternational9 November 2026

Neurotransmitter-specific polygenic scores dissect clinical heterogeneity in schizophrenia

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Schizophrenia (SCZ) is a highly heritable psychiatric disorder characterised by substantial clinical heterogeneity. While global polygenic scores (gPGS) capture genetic liability to SCZ, their ability to explain clinical variability remains limited. Pathway-stratified polygenic scores (sPGS) offer a biologically informed approach to patient stratification. In this study, common genetic variants were annotated across five neurotransmitter (NT) signalling pathways - acetylcholine (ACh), dopamine, gamma-aminobutyric acid (GABA), glutamate (Glu), and serotonin. sPGS adjusted for sex and ancestry p
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.